Teladoc Endorsement Could Be Positive for This ETF

by Trading & Investing | 02/14/2022, 12:35

Healthcare innovation equities are languishing, but it could time for one of the most well-known names in the group to turn around, and that could be constructive for select exchange traded funds, including the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). In a note to clients on Friday, Goldman Sachs analyst Cindy Motz initiated coverage […] Read more at ETFtrends.com.

Dow Finally Clears 45,000 by Knowledge Resources
Weak Jobs Report Stalls Market Momentum by Knowledge Resources
Volatility Closes Below 15 by Knowledge Resources
Record Highs and Overbought Conditions Remain in Focus by Knowledge Resources
Volatility Spikes On Fed Drama by Knowledge Resources